ZVRA logo

Zevra Therapeutics (ZVRA) Operating Expenses

Annual Operating Expenses

$74.12 M
+$39.28 M+112.74%

31 December 2023

ZVRA Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$28.70 M
+$4.03 M+16.32%

30 September 2024

ZVRA Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZVRA Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+112.7%+58.4%
3 y3 years+342.1%+585.4%
5 y5 years+36.6%+297.0%

ZVRA Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+342.1%at high+585.4%
5 y5 yearsat high+342.1%at high+814.5%
alltimeall timeat high+1471.0%at high+1725.6%

Zevra Therapeutics Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$28.70 M(+16.3%)
June 2024
-
$24.67 M(+3.9%)
Mar 2024
-
$23.74 M(-9.0%)
Dec 2023
$74.12 M(+112.7%)
$26.08 M(+44.0%)
Sept 2023
-
$18.11 M(+29.0%)
June 2023
-
$14.04 M(-11.6%)
Mar 2023
-
$15.88 M(+40.4%)
Dec 2022
$34.84 M(+84.7%)
$11.31 M(+20.9%)
Sept 2022
-
$9.36 M(-64.0%)
June 2022
-
$26.02 M(+347.3%)
Mar 2022
-
$5.82 M(+8.4%)
Dec 2021
$18.86 M(+12.5%)
-
Dec 2021
-
$5.37 M(+28.1%)
Sept 2021
-
$4.19 M(-18.7%)
June 2021
-
$5.15 M(+24.0%)
Mar 2021
-
$4.16 M(-25.5%)
Dec 2020
$16.76 M(-44.5%)
$5.58 M(+77.9%)
Sept 2020
-
$3.14 M(-14.6%)
June 2020
-
$3.67 M(-16.0%)
Mar 2020
-
$4.37 M(+13.8%)
Dec 2019
$30.23 M
$3.84 M(-46.9%)
Sept 2019
-
$7.23 M(-7.2%)
DateAnnualQuarterly
June 2019
-
$7.79 M(-31.5%)
Mar 2019
-
$11.37 M(+22.7%)
Dec 2018
$54.27 M(+62.6%)
$9.27 M(-43.2%)
Sept 2018
-
$16.32 M(+17.4%)
June 2018
-
$13.91 M(-5.8%)
Mar 2018
-
$14.77 M(+81.2%)
Dec 2017
$33.37 M(-3.2%)
$8.15 M(-15.2%)
Sept 2017
-
$9.61 M(+16.9%)
June 2017
-
$8.22 M(+11.4%)
Mar 2017
-
$7.38 M(-31.9%)
Dec 2016
$34.47 M(+51.1%)
$10.84 M(+46.6%)
Sept 2016
-
$7.39 M(-20.3%)
June 2016
-
$9.28 M(+33.1%)
Mar 2016
-
$6.97 M(-4.3%)
Dec 2015
$22.81 M(+38.7%)
$7.28 M(+12.4%)
Sept 2015
-
$6.48 M(+8.8%)
June 2015
-
$5.96 M(+92.4%)
Mar 2015
-
$3.10 M(-58.7%)
Dec 2014
$16.44 M(+248.5%)
$7.49 M(+72.6%)
Sept 2014
-
$4.34 M(+42.5%)
June 2014
-
$3.04 M(+93.7%)
Mar 2014
-
$1.57 M
Dec 2013
$4.72 M
-

FAQ

  • What is Zevra Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Zevra Therapeutics?
  • What is Zevra Therapeutics annual operating expenses year-on-year change?
  • What is Zevra Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly operating expenses year-on-year change?

What is Zevra Therapeutics annual total operating expenses?

The current annual operating expenses of ZVRA is $74.12 M

What is the all time high annual operating expenses for Zevra Therapeutics?

Zevra Therapeutics all-time high annual total operating expenses is $74.12 M

What is Zevra Therapeutics annual operating expenses year-on-year change?

Over the past year, ZVRA annual total operating expenses has changed by +$39.28 M (+112.74%)

What is Zevra Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of ZVRA is $28.70 M

What is the all time high quarterly operating expenses for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly total operating expenses is $28.70 M

What is Zevra Therapeutics quarterly operating expenses year-on-year change?

Over the past year, ZVRA quarterly total operating expenses has changed by +$10.58 M (+58.42%)